Trial Profile
Double-blind Multicenter Placebo-controlled Study of the Safety and Leukostimulatory Activity of the Preparation 'Panagen' in Patients With Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Panagen (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
- Indications Advanced breast cancer; Early breast cancer
- Focus Therapeutic Use
- Sponsors Panagen LLC
- 29 Apr 2014 New trial record